CDC panel to meet again next week on J&J vaccine pause
UPDATED 12:30 PM PT – Friday, April 16, 2021
The Centers for Disease Control and Prevention will meet again to decide the fate of the Johnson & Johnson vaccine in the U.S.
During an advisory conference on Friday, CDC Director Rochelle Walensky said the meeting would happen on April 23.
This came after the agency paused the use of the J&J vaccine amid reports of blood clots in about six women. Every state has now put a hold on distributing the vaccine.
Walensky said there is a possibility of more blood clot cases being reported.
“What I would say to the American people is that what we found is really, extremely rare cases through our vaccine safety monitoring system, and that we are transparently, this meeting on Friday will be public,” Walensky explained. “We’ve reached out to over 10,000 providers to ensure that they know what kinds of cases to look for and to do that outreach.”
It is also equally important that people continue to get vaccinated. Both Moderna and Pfizer vaccines are available. If you have not yet been vaccinated, I encourage you to do so with one of the available #COVID19 vaccines as soon as you can.
— Rochelle Walensky, MD, MPH (@CDCDirector) April 16, 2021
“We want to convey to the American public we have two vaccines that are readily available, the Pfizer and the Moderna,” Walensky added. “People should continue to roll up their sleeves to get vaccinated.”
The independent panel suggested they needed more data and more time to look at both the risk and the risk benefit analysis regarding the J&J shot.